Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
02
2019
accepted:
23
07
2019
entrez:
2
8
2019
pubmed:
2
8
2019
medline:
10
3
2020
Statut:
epublish
Résumé
Physical activity (PA) is a known behavior to reduce cancer risk and improve cancer survivorship, yet adherence to PA guidelines is poor among the general population and cancer survivors. The purpose of this study was to determine the extent to which patients referred for exercise consultation within a clinical cancer prevention setting were meeting aerobic and resistance physical activity (PA) guidelines and to identify factors associated with guideline adherence. Between 2013 and 2015, cancer prevention patients and cancer survivors were interviewed by an exercise physiologist within an Integrative Health Program at The University of Texas MD Anderson Cancer Prevention Center. PA adherence was defined as at least 150-minutes of moderate-intensity or 75-minutes of vigorous-intensity PA per week, along with resistance training at least 2 days per week. Logistic regression was used to determine factors associated with meeting or not meeting PA guidelines for aerobic exercise, resistance exercise, and aerobic and resistance exercise combined. Among 1,024 cancer prevention patients and survivors, 9% of patients adhered to guideline-based PA. Adherence to aerobic and resistance guidelines were 20% and 12%, respectively. Overweight or obesity was associated with not meeting guideline-based PA in both cancer prevention patients and cancer survivors. Among breast cancer survivors, combination treatment with surgery, radiation, and chemotherapy ('multimodal therapy') was robustly associated with not meeting aerobic guidelines (OR 2.20, 95% CI: 1.17 to 4.16). BMI and breast cancer treatment history are key determinants of PA behavior among cancer prevention patients and survivors. Poor adherence to PA guidelines is a key issue for cancer prevention patients and survivors, particularly obese patients and women who receive multimodal therapy for breast cancer. Identifying and connecting patients at highest risk of poor PA adherence with exercise programs is needed to improve PA, a key modifiable cancer risk factor.
Identifiants
pubmed: 31369653
doi: 10.1371/journal.pone.0220814
pii: PONE-D-19-03835
pmc: PMC6675393
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0220814Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA057730
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S530-50; discussion S609-10
pubmed: 11427781
JAMA. 2003 Sep 10;290(10):1331-6
pubmed: 12966124
Med Sci Sports Exerc. 2004 Sep;36(9):1484-91
pubmed: 15354027
Ann Behav Med. 2004 Oct;28(2):105-13
pubmed: 15454357
Obesity (Silver Spring). 2007 Dec;15(12):3140-9
pubmed: 18198325
J Clin Oncol. 2008 Aug 20;26(24):3958-64
pubmed: 18711185
Am Surg. 2010 Sep;76(9):962-5
pubmed: 20836343
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1089-97
pubmed: 21467238
BMJ. 2012 Jan 30;344:e70
pubmed: 22294757
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007566
pubmed: 22895961
Breast Cancer Res Treat. 2013 Feb;137(3):869-82
pubmed: 23274845
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):792-802
pubmed: 23462914
Breast Cancer Res Treat. 2013 Apr;138(3):909-16
pubmed: 23504137
J Am Heart Assoc. 2014 Jan 13;3(1):e000432
pubmed: 24419734
Br J Sports Med. 2015 Feb;49(4):224-9
pubmed: 24434186
Support Care Cancer. 2014 Oct;22(10):2757-66
pubmed: 24805910
J Phys Act Health. 2015 May;12(5):675-9
pubmed: 24834485
N Am J Med Sci. 2014 Jul;6(7):295-301
pubmed: 25077076
Prev Chronic Dis. 2014 Sep 11;11:E156
pubmed: 25211504
Cancer Prev Res (Phila). 2015 Feb;8(2):105-10
pubmed: 25416409
Am J Clin Nutr. 2015 Mar;101(3):558-69
pubmed: 25733641
Oncol Nurs Forum. 2015 Mar;42(2):118-27
pubmed: 25806879
BMJ Open. 2015 Apr 28;5(4):e006853
pubmed: 25922098
JAMA Oncol. 2015 May;1(2):231-7
pubmed: 26181028
Eur Urol. 2016 Oct;70(4):576-585
pubmed: 26774959
Maturitas. 2016 Mar;85:104-11
pubmed: 26857888
Support Care Cancer. 2016 Aug;24(8):3533-41
pubmed: 27021390
Am J Public Health. 1989 Jun;79(6):744-50
pubmed: 2729471
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Prev Med. 2017 Jun;99:211-217
pubmed: 28131780
Int J Behav Nutr Phys Act. 2017 Mar 28;14(1):44
pubmed: 28351397
Cochrane Database Syst Rev. 2018 Jan 29;1:CD011292
pubmed: 29376559
Cancer Causes Control. 2018 May;29(4-5):475-484
pubmed: 29511931
Psychooncology. 2018 Oct;27(10):2419-2426
pubmed: 30048023
Med Sci Sports Exerc. 2019 Mar 25;:null
pubmed: 30920488
N Engl J Med. 1997 May 1;336(18):1269-75
pubmed: 9113929